This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Institut de Pharmacologie Moléculaire et Cellulaire | |
|---|---|
| Name | Institut de Pharmacologie Moléculaire et Cellulaire |
| Established | 1984 |
| Type | Research institute |
| Location | Valbonne, Alpes-Maritimes, France |
| Affiliations | Université Côte d'Azur, CNRS |
Institut de Pharmacologie Moléculaire et Cellulaire is a French biomedical research institute located in Valbonne, specializing in molecular pharmacology and cellular physiology. The institute conducts basic and translational research on signaling pathways, receptor biology, and disease mechanisms, linking to clinical applications in oncology, neuroscience, and cardiovascular medicine. Its work interfaces with regional and international organizations, forming networks across academia, industry, and public research agencies.
The institute was founded during the 1980s with support from Centre national de la recherche scientifique, Université de Nice Sophia Antipolis, and local authorities in Alpes-Maritimes. Early collaborations involved groups from Institut Pasteur, Collège de France, and Université Paris-Sud, while landmark projects connected to programs at INSERM, CNES, and Comité des travaux historiques et scientifiques. Over ensuing decades the institute established ties with European Molecular Biology Laboratory, Max Planck Society, Wellcome Trust, and European Research Council, influencing regional initiatives such as the Sophia Antipolis science park and partnerships with Université Côte d'Azur. Notable milestones included participation in consortia with Institut Curie, Gustave Roussy, Hôpitaux Universitaires de Nice, and coordination with Agence nationale de la recherche grants.
Research themes encompass G protein-coupled receptor signaling, ion channel physiology, intracellular trafficking, and cell death pathways, with projects related to oncology, neuroscience, and cardiology. The institute's laboratories investigate mechanisms relevant to PI3K/AKT pathway, MAPK signaling pathway, calcium signaling, and apoptosis as they pertain to targets studied at institutions like Institut Curie, Mount Sinai Hospital, Harvard Medical School, and University College London. Technological emphases mirror platforms at European Molecular Biology Laboratory, such as high-content screening, structural biology collaborations with European Synchrotron Radiation Facility, and single-cell approaches similar to work at Broad Institute and Wellcome Trust Sanger Institute. Projects have linked to drug discovery pipelines observed at Sanofi, Roche, Novartis, AstraZeneca, and Pfizer.
The institute is organized into thematic teams led by principal investigators affiliated with CNRS, INSERM, and Université Côte d'Azur. Leadership has interacted with regional governance including Conseil régional Provence-Alpes-Côte d'Azur and national bodies like Ministère de l'Enseignement supérieur et de la Recherche. Scientific advisory boards have included members from Max Planck Society, Karolinska Institutet, University of Cambridge, Stanford University, Massachusetts Institute of Technology, and Imperial College London. Administrative structures coordinate with funding agencies such as European Research Council, Agence nationale de la recherche, and philanthropic organizations like Fondation pour la Recherche Médicale.
Facilities on site support microscopy platforms comparable to those at European Molecular Biology Laboratory, cryo-electron microscopy resources similar to Max Planck Institute of Biochemistry, proteomics cores reflecting standards of EMBL Hamburg, and animal facilities regulated by Agence nationale de sécurité du médicament et des produits de santé. The institute is located within the Sophia Antipolis science and technology park and houses cell culture suites, high-throughput screening labs inspired by Broad Institute, and bioinformatics clusters aligned with practices at Institut Pasteur, European Bioinformatics Institute, and CNRS computing centers. Infrastructure development has mirrored projects seen at Institut Curie and Gustave Roussy.
The institute hosts doctoral students and postdoctoral researchers enrolled through Université Côte d'Azur, collaborative doctoral programs with Université Paris-Sud, and international exchanges with University of California, San Francisco, ETH Zurich, University of Oxford, McGill University, and University of Tokyo. Training covers advanced microscopy, proteomics, and computational biology using curricula similar to those at Karolinska Institutet and Harvard Medical School. It participates in graduate schools and summer programs connected to Ecole Normale Supérieure, École Polytechnique, and international training networks funded by the European Commission.
Collaborative agreements exist with clinical centers such as Hôpitaux Universitaires de Nice, research institutions including CNRS, INSERM, Institut Curie, and industrial partners like Sanofi, BioMérieux, and Medtronic. International research collaborations have included projects with European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Broad Institute, Max Planck Society, Karolinska Institutet, University of Cambridge, Stanford University, and Harvard Medical School. The institute engages in EU-funded consortia under Horizon 2020 and regional innovation schemes directed by Conseil régional Provence-Alpes-Côte d'Azur.
Teams and investigators have received grants and honors from bodies including the European Research Council, Agence nationale de la recherche, Fondation ARC, Fondation pour la Recherche Médicale, and international fellowships from Wellcome Trust and Marie Skłodowska-Curie Actions. Publications and discoveries have been recognized in journals associated with Nature Publishing Group, Cell Press, and American Association for the Advancement of Science awards, with researchers invited to speak at meetings such as the Gordon Research Conferences, Society for Neuroscience, and European Society for Clinical Investigation.
Researchers and alumni have moved to positions at Université Côte d'Azur, Institut Pasteur, Institut Curie, Gustave Roussy, Inserm, CNRS, École Polytechnique, Université Paris-Saclay, University of Oxford, Harvard Medical School, Stanford University, Karolinska Institutet, Max Planck Society, European Molecular Biology Laboratory, Wellcome Trust Sanger Institute, Broad Institute, Sanofi, Novartis, Roche, and AstraZeneca. Alumni include principal investigators who later joined faculties at Université de Montréal, McGill University, MPI of Biochemistry, ETH Zurich, University College London, Imperial College London, and leadership roles in biotech firms such as bioMérieux and Valneva.
Category:Research institutes in France